ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,224.00
0.37%
S&P ASX All Technology
3,793.80
1.40%
Brent Oil
72.935
1.49%
US Dollar vs AUD
1.54579
0.36%
Bitcoin
91,078.96
0.57%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Ikonisys SA (ALIKO) Share Price

Ikonisys SA

Ikonisys SA (ALIKO)

EU
1.47
0.00
( 0.00% )
Updated: 21:40:44
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.47
Bid
1.42
Offer
1.47
Volume
215
1.45 Day's Range 1.47
1.23 52 Week Range 1.80
Market Cap
15.364M
Previous Close
1.47
Open
1.45
Last Trade
5
@
1.47
Last Trade Time
21:32:36
Financial Volume
-
VWAP
-
Average Volume (3m)
7,392
Shares Outstanding
10,451,424
Dividend Yield
-
PE Ratio
-6.78
Earnings Per Share (EPS)
-0.22
Revenue
448k
Net Profit
-2.27M

About Ikonisys SA

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.ikonisys.com
Headquarters
Paris, Paris, Fra
Founded
-
Ikonisys SA is listed in the Surgical,med Instr,apparatus sector of the Euronext with ticker ALIKO. The last closing price for Ikonisys was 1.47 €. Over the last year, Ikonisys shares have traded in a share price range of 1.23 € to 1.80 €.

Ikonisys currently has 10,451,424 shares in issue. The market capitalisation of Ikonisys is 15.36 € million. Ikonisys has a price to earnings ratio (PE ratio) of -6.78.

Ask ADVFN Intelligence (AI)

ALIKO Latest News

More News

Ikonisys Group Renews Agreement as European Authorized Representative and Importer for Novodiax’s CE IVD-Certified Real-Time Immunohistochemistry Technology in Oncological Diagnostics and Organ Transplant Safety

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis...

13 November 2024
Business Wire

Ikonisys débute une collaboration avec SYNLAB Italie pour introduire l'Ikoniscope au sein des laboratoires de pathologie

Regulatory News: Ikonisys SA (Euronext Growth Paris : ALIKO), une entreprise spécialisée dans la détection précoce et précise des cancers grâce à une solution unique et entièrement automatisée...

05 November 2024
Business Wire

Ikonisys Publishes Its 2024 Half-Year Financial Results

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis...

01 November 2024
Business Wire

Ikonisys Completed a Capital Increase Through a Private Placement

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis...

15 October 2024
Business Wire

Ikonisys Announces That Hospitex International Won the Public Tender of the Prestigious U.O.C. Pathological Anatomy of Enna in Italy

Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancer through fully automated solutions for medical laboratories, is...

10 October 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.03-21.51.51.448921.4424486DE
4-0.13-8.1251.61.61.433671.49001221DE
12001.471.711.473921.58572628DE
260.0751.41.711.3861141.51509659DE
520.0751.41.81.2376691.51358648DE
156-1.24-45.75645756462.713.11.1436571.62613382DE
260-2.67-64.49275362324.144.71.1439591.93471511DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
3.06M
ALSRSSirius Media
0.0177 €
(38.28%)
8.4M
MLUMGUmalis Group
1.89 €
(18.13%)
1.71k
ALMDPMedesis Pharma SA
0.44 €
(14.29%)
63.89k
MLLOILocasystem International
14.00 €
(12.90%)
10
ATODSAtos SE
0.0187 €
(-38.08%)
3.42M
MLACTActivium Group
1.39 €
(-32.52%)
1.05k
ATOAtos SE
0.205 €
(-31.23%)
6.6M
EBUSREbusco
0.37 €
(-19.57%)
566.03k
COCasino Guichard Perrachon
1.7072 €
(-16.27%)
508.73k
BCPBanco Comercial Portugues SA
0.4406 €
(0.09%)
19.63M
ALTDTonner Drones
0.01 €
(-1.96%)
15.45M
ALDRVDrone Volt
0.0036 €
(-2.70%)
12.25M
ALNEVNeovacs
0.0002 €
(0.00%)
11.82M
ALRPDRapid Nutrition
0.064 €
(6.67%)
10.8M

Discussion

View Full Feed
TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
Interesting stock price
RVVTF
gladeshawk gladeshawk 4 minutes ago
"IF" they get a handle on things, mostly production, next year could be a breakout year for them. "IF" so then the pps is vastly undervalued. HAWK
GOEV
MrJOhanDao96 MrJOhanDao96 4 minutes ago
Time to hold more.
CGAC
manibiotech manibiotech 4 minutes ago
The restarting statement has been there for years in the filings if I remember correctly . But they want market to believe this time we really mean it . And even if the trials restart , they have yet to prove to market their credibility in getting a single approval in half a decade after a data lock
NWBO
Hercules1 Hercules1 4 minutes ago
https://x.com/BitcoinMagazine/status/1857063826664878382
BTCT
Jack Torrance Jack Torrance 4 minutes ago
I think a buyout is a very real possibility, if for no other reason than big pharma doesn't want a small fry like MindMed becoming a giant and eating into their revenue. That's the corporate way: If you can't beat 'em, buy 'em.
MNMD
TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
A lot of debt
RVVTF
TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
What makes you come up with $4
RVVTF
deri21 deri21 4 minutes ago
$CBMJ CBMJ’s "Supporting Patriots" Launches Shopping Channel to 30 Million Samsung TVs Showcasing Made in USA Products Seen on Patriot.TV
https://www.accesswire.com/942364/cbmjs-supporting-patriots-launches-shopping-channel-to-30-million-samsung-tvs-showcasing-made-in-usa-products-seen-on-pa
CBMJ
TLIPK5269 TLIPK5269 5 minutes ago
Fannie/Freddie was talked about on Maria Bartiromo Fox Business this morning (11/14) Around 8:28 Am Eastern time. Topic was recent double ling of stock price and exit from conservatorship in the Trump Administration and will be the biggest IPO in History
FNMA
IVRT IVRT 5 minutes ago
https://www.brookmountgold.com/investor-relations
BMXI
al44 al44 5 minutes ago
GM Gmenfan-

That sounds about right. No phones, no computers, just things kids did for years by themselves or with cohorts.

...................al
x993231 x993231 5 minutes ago
They either borrow money in which case they are constantly dealing with refinancing and we all know what happens every time you renegotiate a loan or they sell the shares that we authorized a few years ago to fund operations. Prior to that they did private placements but they come with warrants so
LWLG
AveragePenny AveragePenny 5 minutes ago
$VAPR E-Cite' CEO and COO Invest Heavily, Converting Loans and Deferred Compensation to Restricted Stock at Double Market Price Reducing Related Party Payables by over 90% and Total Liabilities by over 50%

https://www.accesswire.com/942430/e-cite-ceo-and-coo-invest-heavily-converting-
VAPR
Savannah-Marc Savannah-Marc 5 minutes ago
Full legalization is near!!!!!!!
https://www.msn.com/en-us/money/markets/cannabis-stocks-gain-as-trump-picks-pro-marijuana-congressman-gaetz-for-ag-post/ar-AA1u4D6K?ocid=finance-verthp-feeds
PLNH
EyeInTheSky EyeInTheSky 5 minutes ago
https://x.com/artdigitalcorp/status/1856025366688669813?t=l-sP8Kh0_-kkzWABO5KKaQ&s=19
CGAC
BIOCHEMUP BIOCHEMUP 5 minutes ago
lol
AFFU
TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
Funny volume
SBFM
deri21 deri21 6 minutes ago
$VAPR E-Cite' CEO and COO Invest Heavily, Converting Loans and Deferred Compensation to Restricted Stock at Double Market Price Reducing Related Party Payables by over 90% and Total Liabilities by over 50%
https://www.accesswire.com/942430/e-cite-ceo-and-coo-invest-heavily-converting-loans-an
VAPR
learningcurve2020 learningcurve2020 6 minutes ago
Seems obvious that's the single ancient Plll would not be taken seriously by the FDA or EMA.  It's why they waited for MHRA to detach from EMA before submitting.   The other regulators are probably saying to MHRA If you want to stick your neck out on this one that's your business but we'll sit back
NWBO
TRUSTUNITS1000000 TRUSTUNITS1000000 6 minutes ago
Down yesterday
SBFM
BlazingStocks BlazingStocks 6 minutes ago
$ILLR Article October 16, 2024

Triller merges with financial services and healthcare firm AGBA
https://musically.com/2024/10/16/triller-merges-with-financial-services-and-healthcare-firm-agba/
ILLR
IVRT IVRT 6 minutes ago
https://www.brookmountgold.com/disclosures
BMXI
INTHEKNOW1 INTHEKNOW1 6 minutes ago
AFFU .0012 BEST DEAL ON OTC (WHY INSIDE) https://x.com/jobicat/status/1857058499483570562
AFFU

Your Recent History

EU
ALIKO
Ikonisys
TSX
FCU
Fission Uranium
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved